Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
BNT111 + Cemiplimab for Melanoma
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is designed to see if a combination of two drugs is more effective than either drug alone in treating patients with melanoma that has spread and is no longer responding to other treatments.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.